Cite
Stein EM, DeAngelo DJ, Chromik J, et al. Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type . Clin Cancer Res. 2021;doi: 10.1158/1078-0432.CCR-21-1295.
Stein, E. M., DeAngelo, D. J., Chromik, J., Chatterjee, M., Bauer, S., Lin, C. C., Suarez, C., De Vos, F., Steeghs, N., Cassier, P. A., Tai, D., Kiladjian, J. J., Yamamoto, N., Mous, R., Esteve, J., Minami, H., Ferretti, S., Guerreiro, N., Meille, C., Radhakrishnan, R., Pereira, B., Mariconti, L., Halilovic, E., Fabre, C., & Carpio, C. (2021). Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type . Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-1295
Stein, Eytan M, et al. "Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type ." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2021). doi: https://doi.org/10.1158/1078-0432.CCR-21-1295
Stein EM, DeAngelo DJ, Chromik J, Chatterjee M, Bauer S, Lin CC, Suarez C, De Vos F, Steeghs N, Cassier PA, Tai D, Kiladjian JJ, Yamamoto N, Mous R, Esteve J, Minami H, Ferretti S, Guerreiro N, Meille C, Radhakrishnan R, Pereira B, Mariconti L, Halilovic E, Fabre C, Carpio C. Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type . Clin Cancer Res. 2021 Dec 03; doi: 10.1158/1078-0432.CCR-21-1295. Epub 2021 Dec 03. PMID: 34862243.
Copy
Download .nbib